Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description

Hot topics
Chairs: E. Piitulainen (Malmö, Sweden), M. Miravitlles (Barcelona, Spain)
Aims: The aim of this session is to provide an overview of the recent developments in the field of AATD that impact on our understanding of the disease and the pathogenesis of usual COPD in smokers. An introduction into specific management of AATD and the development of novel therapies for pulmonary emphysema related to AATD.
Contributions to the understanding of the natural history and genetic epidemiology of AATD over 50 years
M. Luisetti (Pavia, Italy)
Slide presentationMultimedia files
Slide presentationMultimedia files
The search for evidence of the efficacy of augmentation therapy in AATD
R. Sandhaus (Miami, United States of America)
Slide presentationMultimedia files
Slide presentationMultimedia files
AATD: Implications for our understanding of usual COPD
R. A. Stockley (Birmingham, United Kingdom)
Slide presentationMultimedia files
Slide presentationMultimedia files
New treatment strategies in AATD
A. Turner (Birmingham, United Kingdom)
Slide presentationMultimedia files
Slide presentationMultimedia files